Nilsson G, Nordlander S, Levin K
Acta Med Scand. 1976;200(1-2):63-67. doi: 10.1111/j.0954-6820.1976.tb08197.x.
Subclinical hypothyroidism is an example of the impact of technology on the concept of a disease. It denotes a condition in which laboratory findings, at least including a raised serum thyrotropin (s-TSH), indicate hypothyroidism in the absence of clinical signs or symptoms of this disease. One reason for attention to cases of subclinical hypothyroidism is the publication of reports, from the time before introduction of the s-TSH assay, that hypercholesterolaemia precedes other evidence of thyroid failure with attendant risks of ischaemic heart disease and other atherosclerotic manifestations. The present investigation, which concerned the lipid pattern in sublinical hypothyroiism, offered no support for such a concept of hypercholesterolaemia as a premonitory sign of hypothyroidism. Furthermore, no significant differences were found between the serum levels of cholesterol and triglycerides before and after the administration of a thyroxine dose, necessary to suppress the s-TSH into a normal range, in cases of sublinical hypothyroidism. Nor were there any changes during this therapy in body weight, ECG, or Hb levels, which represent important parameters often found to be abnormal in overt hypothyroidism. From a practical point of view, subclinical hypothyroidism probably can be regarded as a state in which reduction of thyroid activity has been compensated by an increased s-TSH secretion to maintain a clinically euthyroid state. When no goitre is found, the rationale of treatment of this condition remains to be proved.
亚临床甲状腺功能减退是技术对疾病概念产生影响的一个例子。它指的是一种情况,即实验室检查结果,至少包括血清促甲状腺素(s-TSH)升高,表明存在甲状腺功能减退,但并无该疾病的临床体征或症状。关注亚临床甲状腺功能减退病例的一个原因是,在s-TSH检测方法引入之前就有报告称,高胆固醇血症先于甲状腺功能减退的其他证据出现,伴有缺血性心脏病和其他动脉粥样硬化表现的风险。本次关于亚临床甲状腺功能减退患者血脂模式的调查,并未支持将高胆固醇血症视为甲状腺功能减退先兆的这一概念。此外,在亚临床甲状腺功能减退患者中,给予能将s-TSH抑制到正常范围所需剂量的甲状腺素前后,血清胆固醇和甘油三酯水平并无显著差异。在这种治疗过程中,体重、心电图或血红蛋白水平也没有变化,而这些在明显的甲状腺功能减退中常常是重要的异常参数。从实际角度来看,亚临床甲状腺功能减退可能可被视为一种甲状腺活性降低已通过s-TSH分泌增加得到代偿以维持临床甲状腺功能正常状态的情况。当未发现甲状腺肿时,这种情况的治疗依据仍有待证实。